XETRA - Delayed Quote EUR
CureVac N.V. (5CV.DE)
3.6000
+0.0400
+(1.12%)
At close: May 23 at 5:35:40 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 6 |
| Avg. Estimate | 4.27M | 4.27M | 80.5M | 99.92M |
| Low Estimate | -- | -- | 51.1M | 61.2M |
| High Estimate | 12.8M | 12.8M | 105M | 158.53M |
| Year Ago Sales | 14.44M | 493.9M | 535.2M | 80.5M |
| Sales Growth (year/est) | -70.44% | -99.14% | -84.96% | 24.11% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 5CV.DE | -- | -- | -- | -- |
| S&P 500 | 12.65% | 2.49% | 7.39% | 14.05% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 4/30/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/14/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 9/16/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/16/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 7/3/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 4/25/2024 |
Related Tickers
22UA.DE BioNTech SE
85.90
-1.26%
0QF.DE Moderna, Inc.
22.70
-2.34%
HPHA.DE Heidelberg Pharma AG
3.3100
-0.90%
AYJ.F Valneva SE
2.7780
-2.32%
0QF.F Moderna, Inc.
22.93
-1.76%
BIO3.DE Biotest Aktiengesellschaft
30.00
0.00%
7V0.DE Darwin AG
30.20
+2.03%
PRTCl.XC
88Q.DE 4basebio PLC
13.10
0.00%
4880.T CellSource Co., Ltd.
629.00
-1.10%